These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


136 related items for PubMed ID: 3304029

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Randomized placebo-controlled, double-blind trial of ketanserin in treatment of intermittent claudication.
    Walden R, Bass A, Rabi I, Adar R.
    J Cardiovasc Surg (Torino); 1991; 32(6):737-40. PubMed ID: 1752890
    [Abstract] [Full Text] [Related]

  • 3. Effect of ketanserin in the treatment of patients with intermittent claudication: results from 13 placebo-controlled parallel group studies.
    Clement DL, Duprez D.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S89-95. PubMed ID: 2446082
    [Abstract] [Full Text] [Related]

  • 4. Ketanserin in intermittent claudication. A double-blind placebo-controlled study.
    Clement DL, Duprez D, Van Wassenhove A, Brusselmans F.
    Int Angiol; 1989; 8(2):92-6. PubMed ID: 2681451
    [Abstract] [Full Text] [Related]

  • 5. Randomized placebo-controlled, double-blind trial of ketanserin in claudicants. Changes in claudication distance and ankle systolic pressure. PACK Claudication Substudy.
    Circulation; 1989 Dec; 80(6):1544-8. PubMed ID: 2688971
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of ketanserin on macrocirculatory and microcirculatory blood flow in patients with intermittent claudication. A prospective randomized study.
    Beckers RC, Jörning PJ, Slaaf DW, Reneman RS, Jacobs MJ.
    Eur J Clin Pharmacol; 1989 Dec; 37(3):295-6. PubMed ID: 2693113
    [Abstract] [Full Text] [Related]

  • 13. The effect of a combined administration of ridogrel and ketanserin in patients with intermittent claudication.
    De Cree J, Geukens H, Gutwirth P, De Clerck F, Vercammen E, Verhaegen H.
    Int Angiol; 1993 Mar; 12(1):59-68. PubMed ID: 8376914
    [Abstract] [Full Text] [Related]

  • 14. Effects of pentoxifylline on severe intermittent claudication.
    Reich T, Gillings D.
    Angiology; 1987 Sep; 38(9):651-6. PubMed ID: 3310744
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A double-blind, placebo-controlled study of the effects of policosanol in patients with intermittent claudication.
    Castaño G, Más R, Roca J, Fernández L, Illnait J, Fernández JC, Selman E.
    Angiology; 1999 Feb; 50(2):123-30. PubMed ID: 10063942
    [Abstract] [Full Text] [Related]

  • 17. Effect of cloricromene on intermittent claudication. A randomized, double-blind, placebo-controlled trial in patients treated with aspirin: effect on claudication distance and quality of life. CRAMPS Investigator Group. Cloricromene Randomized Arteriopathy Multicenter Prospective Study.
    Gresele P, Migliacci R, Di Sante G, Nenci GG, CRAMPS Investigator Group.
    Vasc Med; 2000 Feb; 5(2):83-9. PubMed ID: 10943584
    [Abstract] [Full Text] [Related]

  • 18. Acute effect of ketanserin on the leg perfusion assessed by Doppler pressure measurements and 201Tl scintigraphy in patients with intermittent claudication.
    Bounameaux H, Devos P, Verhaeghe R.
    J Cardiovasc Pharmacol; 1985 Feb; 7(6):1083-6. PubMed ID: 2418292
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.